Contraceptives Market
Contraceptives Market Study by Contraceptive Drugs and Contraceptive Devices for Hospital Pharmacies, Independent Pharmacies, Online Platforms, and Clinics from 2023 to 2033
Analysis of Contraceptives Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Contraceptives Market Outlook (2023 to 2033)
Global demand for contraceptives is predicted to increase at a CAGR of 6.5% from 2023 to 2033. As a result, the global contraceptives market size is set to increase from a value of US$ 33 billion to US$ 62 billion by the end of 2033.
The use of contraceptive devices is being driven by robust government campaigns and programs for women's and children's health. Women who do not want to utilize the hormonal form to prevent potential adverse effects typically prefer copper intrauterine devices (IUDs).
A way of preventing pregnancy known as contraception uses medication or a device. It is sometimes referred to as fertility control or birth control. Pregnancy during intercourse is prevented by the use of contraception. There are various contraceptive methods available; the most effective one depends on one's health and situation. To prevent conception, contraceptive methods or medications disrupt the normal sperm-ovum fertilization process.
Contraception prevents pregnancy by interfering with the natural processes of fertilization, ovulation, and implantation through the use of medications, medical devices, and surgical procedures. Contraceptive medicines also prevent sexually transmitted diseases (STDs). Contraceptive devices, which are primarily composed of plastic or metal, come in a variety of shapes, including loop, coil, T-shaped, and triangle.
Key factors influencing the market are the increased development of effective female contraceptive drugs and devices, technological advancements, an increase in government and non-governmental organization initiatives to promote contraceptives, and the implementation of the Patient Protection Act. The growing prevalence of sexually transmitted diseases and the need for population control are the factors driving market growth.
The market is anticipated to be driven by the implementation of efforts aiming at reducing unintended births and the ensuing development in user awareness levels. Along with these factors, the rise in the use of oral tablets as a primary method of contraception and the health problems connected to teenage pregnancies are fueling market growth.
The fundamental right to privacy guaranteed by the United States Constitution includes the ability to obtain and use contraceptives. The development of emergency oral contraceptive tablets is just one example of the numerous technological advancements in contraceptive medications that have fueled industry expansion.
Older combined oral contraceptives (COCs) containing 50 micrograms of estrogen have mainly been replaced by low-dose COCs containing 20–35 micrograms of ethinylestradiol in combination with progestogen. Because there is a lesser chance of venous thromboembolism, low-dose COCs are preferred. A good growth trajectory will be strongly suggested by the increase in clinical studies relevant to birth control methods for enhanced efficacy throughout the forecast period.
Report Attributes |
Details |
|
Contraceptives Market Size (2023) |
US$ 33 Billion |
|
Projected Market Value (2033) |
US$ 62 Billion |
|
Global Market Growth Rate (2023 to 2033) |
6.5% CAGR |
|
Market Share of Contraceptive Devices |
50% |
|
Key Companies Profiled |
|
Why are Sales of Contraceptives Increasing Rapidly across Regions?
“Rise in Unwanted Pregnancies and Growing Prevalence of Sexually Transmitted Diseases”
Most unwanted pregnancies occur among adolescents and young women. Such pregnancies are a major source of the prevalence of sexually transmitted diseases (STDs) such as HIV, chlamydia, genital herpes, and hepatitis B.
With this ever-increasing risk, there is a rise in awareness about modern contraceptives. Governments from different countries are conducting major campaigns and sex education programs to raise youth awareness and encourage the use of contraception to prevent STDs and unintended births.
Increased demand for sexual and reproductive health services as well as contemporary contraception methods are being met by several government initiatives. All steps of these health services' evaluation, implementation, and planning should involve children, teenagers, and women.
Since many women now prioritize their careers over having children, many are delaying motherhood. In addition to the rising prevalence of unstable relationships and worries about job safety, more women are becoming aware of the costs incurred when raising children. The market for contraceptives is projected to expand as people become more aware of the need of making the right decisions regarding their sexual and reproductive health.
The World Health Organization collaborates with partners at the international, regional, and national levels to strengthen and enhance family planning and reproductive health outcomes. To address the unmet need for family planning, these partnerships will streamline family planning programs, increase access to contraceptive technologies and supplies, and mobilize international commitments. Human rights are becoming a more important consideration for contraceptive services and programs.
Additionally, the health risks connected to young pregnancies, a rise in the use of oral tablets as a primary method of contraception, and increased awareness of modern contraception all contribute to market expansion. Business revenue will be favorably impacted by supportive family planning policies as well as other reimbursement policies such as the AIDS care policy.
Other trends, notably the introduction of new, innovative, and low-cost contraceptive devices by key market players are also expected to significantly leverage the contraceptives market. For instance, Agile Therapeutics is performing a stage 3 trial for Twirla, a contraceptive patch designed to deliver a low daily dose of estrogen.
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What is Hampering Global Demand Growth for Contraceptives?
“Side Effects Related to Use of Contraceptives and Lack of Societal Acceptance”
The contraceptives market could be negatively impacted by the side effects related to the use of contraceptives, the availability of alternative contraceptive methods, and a lack of societal acceptance. Pricing trends indicate that the high costs of some contraceptive devices are hampering market growth.
How are Emerging Market Players Penetrating This Industry?
“New Companies Introducing Modern & Fast-reacting Contraceptives Without Side Effects”
Upcoming market players are focusing on quality control of products and new developments in biotechnology such as targeted medication to broaden their market footprint. Start-ups are creating modern contraceptives that let women plan their families without risky side effects.
- OUI is a vaginal capsule made by the Danish start-up Cirqle Biomedical that dissolves quickly and releases its formulation when inserted. Within a minute of delivering OUI, the start-up claims effective contraception without negative side effects.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Which Region Accounts for a Leading Position in the Contraceptives Market?
“Huge Demand for Reversible Contraceptives in North America”
North America accounts for 50% share of the global market owing to the growing prevalence of unintended pregnancies, rising demand for reversible contraceptives, and public sector initiatives to provide funding for family planning and contraception. High abortion rates and the introduction of generic and affordable medications and devices, and the presence of top contraceptive suppliers are fueling market value in the region.
Country-wise Insights
Why is the United States Considered a Profitable Market for Contraceptive manufacturers?
“Rising Rate of Teenage Pregnancies in the Country”
One of the top producers and consumers of contraceptives worldwide is the United States. The market in the United States is anticipated to experience rapid growth due to the existence of advanced medical facilities, the high acceptance rate of contraceptive medications, and well-established distribution channels.
The majority of the female population in the country is of reproductive age. Additionally, the rising rate of teenage pregnancies in the United States will support regional expansion.
How is Demand for Contraceptives Evolving in Germany?
“Favorable Reimbursement Policies for Use of Contraceptives”
An increase in financing for clinical trials of modern birth control drugs and favorable reimbursement policies for the use of contraceptives are the elements supporting market expansion in Germany.
What is Benefitting Manufacturers of Contraceptives in Japan?
“Expanding Government Initiatives to Increase Public Awareness of Family Planning”
Japan is emerging as a burgeoning market for contraceptives. The high incidence of the spread of STDs due to a rapidly expanding population is a key motivator for market growth. Expanding government initiatives to increase public awareness of family planning and women's health and a rise in the local supply of external physical barriers such as condoms are the factors boosting market expansion.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Insights
Why are Contraceptive Devices Gaining Immense Popularity?
“Contraceptive Devices Gaining Traction Due to Their Excellent Efficacy in Regular Monitoring of Women's Health”
Based on product, the market is divided into contraceptive devices and contraceptive drugs. Contraceptive devices account for 50% share of the global market due to the increasing product approvals to meet the escalating demand for such medical devices, as well as their excellent efficacy in regular monitoring of women's health.
Contraceptive devices are gaining traction owing to the major side effects of ingesting contraceptive drugs, particularly among women. These include nausea, headache, weight gain, increased bleeding, dysmenorrhea, and menstrual changes.
Some of the most widely used devices are condoms, diaphragms, sponges, rings, sub-dermal implants, and intrauterine devices (IUDs). The most extensively used product is the condom. Moreover, the introduction of custom-fit condoms by key market players is expected to drive the demand for contraceptive devices.
Which Distribution Channel is Leading the Sales of Contraceptives?
“Hospital Pharmacies More Preferred Owing to Easy Accessibility of Various Contraceptive Products”
The market is divided into hospital pharmacies, independent pharmacies, online platforms, clinics, and others on the basis of the distribution channel. Hospital pharmacies are preferred by individuals due to an increase in hospital partnerships with distributors and manufacturers, particularly for birth control devices. The easy accessibility of various contraceptive products, improved supply chain management, and growing public awareness of various birth control tablets are boosting the sales of contraceptives through hospital pharmacies.
Competitive Landscape
Leading companies are concentrating on R&D initiatives to launch modern contraceptive devices following safety regulations to reduce the environmental impact. Top contraceptive providers are involved in acquiring and collaborating with other businesses and enhancing product standards.
For instance,
- In 2021, Generate Life Sciences was acquired by Cooper Surgical, Inc. Cooper's reproductive section is improved by this acquisition.
- In 2021, Clue introduced a digital birth control method that provides customers with an ovulation prediction based on statistics.
- Pfizer Inc’s Sayana Press is the first injectable contraceptive for women available in the U.K. The company is also in the process of conducting a study evaluating levonorgestrel and Ethinyl estradiol as potential oral contraceptives.
- Merck & Co, Inc., offers contraceptive care in the form of combined oral pills, vaginal rings, intrauterine devices, and sub-dermal implants. Popular products include Cyclessa, Desogen, NuvaRing, Implanon, and Nexplanon.
- Cipla manufactures oral contraceptives named Crisanta. The medicine contains Drospirenone, which prevents the fertilization of the egg with the sperm. It also induces hormonal changes contributing to the prevention of pregnancy.
Key Segments of Contraceptives Industry Research
-
By Product :
- Contraceptive Drugs
- Oral Contraceptives
- Combined Contraceptives
- Mini pills
- Contraceptive Injectable
- Topical Contraceptive Patch
- Oral Contraceptives
- Contraceptive Devices
- Male Contraceptive Devices
- Female Contraceptive Devices
- Female Condoms
- Contraceptive Diaphragms
- Contraceptive Sponges
- Contraceptive Vaginal Rings
- Intrauterine Devices
- Sub-dermal Contraceptive Implants
- Non-surgical Permanent Contraception Devices
- Contraceptive Drugs
-
By Distribution Channel :
- Hospital Pharmacies
- Independent Pharmacies
- Online Platforms
- Clinics
- Others
-
By Region :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Content
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 2. Assumptions and Research Methodology 2.1. Assumptions and Acronyms Used 2.2. Research Methodology 3. Executive Summary 3.1. Global Contraceptive Market Size (US$ Mn) and Forecast, by Region, 2023 and 2033 3.2. Global Contraceptive Market: Market Snapshot 4. Market Overview 4.1. Global Contraceptive Market Overview 4.2. Global Contraceptive Market Key Industry Developments 5. Market Dynamics 5.1. Drivers and Restraints Snapshot Analysis 5.2. Drivers 5.3. Restraints 5.4. Opportunities 5.5. Key Trends 5.6. Global Contraceptive Market Revenue Projections (US$ Mn), 2023–2033 5.7. Regulatory Framework 5.8. Heat Map Analysis - Company 6. Global Contraceptive Market Analysis, by Product 6.1. Introduction 6.2. Key Insights 6.3. Global Contraceptive Market Size and Forecast, by Product 6.3.1. Contraceptive Drugs 6.3.1.1. Oral Contraceptives 6.3.1.1.1. Combined Contraceptives 6.3.1.1.2. Mini-pills 6.3.1.2. Contraceptive Injectable 6.3.1.3. Topical Contraceptive Patch 6.3.2. Contraceptive Injectable 6.3.2.1. Male Contraceptive Devices 6.3.2.2. Female Contraceptive Devices 6.3.2.2.1. Female Condoms 6.3.2.2.2. Contraceptive Diaphragms 6.3.2.2.3. Contraceptive Sponges 6.3.2.2.4. Contraceptive Vaginal Rings 6.3.2.2.5. Intrauterine Devices 6.3.2.2.6. Sub-dermal Contraceptives Implants 6.3.2.2.7. Non-Surgical Permanent Contraception Devices 6.4. Global Contraceptive Market Analysis, by Product 6.5. Global Contraceptive Market Attractiveness Analysis, by Product 7. Global Contraceptive Market Analysis, by Distribution Channel 7.1. Introduction 7.2. Key Insights 7.3. Global Contraceptive Market Size and Forecast, by Distribution Channel 7.3.1. Hospital Pharmacy 7.3.1.1. Public 7.3.1.2. Private 7.3.2. Independent Pharmacy 7.3.3. Online Platform 7.3.4. Clinics 7.3.5. Others 7.4. Global Contraceptive Market Analysis, by Distribution Channel 7.5. Global Contraceptive Market Attractiveness Analysis, by Distribution Channel 8. Global Contraceptive Market Analysis, by Region 8.1. Introduction 8.2. Key Insights 8.3. Global Contraceptive Market Size and Forecast , by Region, 2018–2033 8.3.1. North America 8.3.2. Europe 8.3.3. Asia Pacific 8.3.4. Latin America 8.3.5. Middle East & Africa 8.4. Global Contraceptive Market Analysis, by Region 8.5. Global Contraceptive Market Attractiveness Analysis, by Region 9. North America Contraceptive Market Analysis 9.1. North America Contraceptive Market Key Findings 9.2. North America Contraceptive Market Overview 9.3. North America Contraceptive Market Size and Forecast, by Product 9.3.1. Contraceptive Drugs 9.3.1.1. Oral Contraceptives 9.3.1.1.1. Combined Contraceptives 9.3.1.1.2. Mini-pills 9.3.1.2. Contraceptive Injectable 9.3.1.3. Topical Contraceptive Patch 9.3.2. Contraceptive Injectable 9.3.2.1. Male Contraceptive Devices 9.3.2.2. Female Contraceptive Devices 9.3.2.2.1. Female Condoms 9.3.2.2.2. Contraceptive Diaphragms 9.3.2.2.3. Contraceptive Sponges 9.3.2.2.4. Contraceptive Vaginal Rings 9.3.2.2.5. Intrauterine Devices 9.3.2.2.6. Sub-dermal Contraceptives Implants 9.3.3. Non-Surgical Permanent Contraception Devices 9.4. North America Contraceptive Market Size and Forecast, by Distribution Channel 9.4.1. Hospital Pharmacy 9.4.1.1. Public 9.4.1.2. Private 9.4.2. Independent Pharmacy 9.4.3. Online Platform 9.4.4. Clinics 9.4.5. Others 9.5. North America Contraceptive Market Forecast, by Country 9.5.1. U.S. 9.5.2. Canada 9.6. North America Contraceptive Market Attractiveness Analysis 9.6.1. By Product 9.6.2. By Distribution Channel 9.6.3. By Country 10. Europe Contraceptive Market Analysis 10.1. Europe Contraceptive Market Key Findings 10.2. Europe Contraceptive Market Overview 10.3. Europe Contraceptive Market Size and Forecast, by Product 10.3.1. Contraceptive Drugs 10.3.1.1. Oral Contraceptives 10.3.1.1.1. Combined Contraceptives 10.3.1.1.2. Mini-pills 10.3.1.2. Contraceptive Injectable 10.3.1.3. Topical Contraceptive Patch 10.3.2. Contraceptive Injectable 10.3.2.1. Male Contraceptive Devices 10.3.2.2. Female Contraceptive Devices 10.3.2.2.1. Female Condoms 10.3.2.2.2. Contraceptive Diaphragms 10.3.2.2.3. Contraceptive Sponges 10.3.2.2.4. Contraceptive Vaginal Rings 10.3.2.2.5. Intrauterine Devices 10.3.2.2.6. Sub-dermal Contraceptives Implants 10.3.3. Non-Surgical Permanent Contraception Devices 10.4. Europe Contraceptive Market Size and Forecast, by Distribution Channel 10.4.1. Hospital Pharmacy 10.4.1.1. Public 10.4.1.2. Private 10.4.2. Independent Pharmacy 10.4.3. Online Platform 10.4.4. Clinics 10.4.5. Others 10.5. Europe Contraceptive Market Forecast, by Country 10.5.1. Germany 10.5.2. U.K. 10.5.3. France 10.5.4. Spain 10.5.5. Italy 10.5.6. Rest of Europe 10.6. Europe Contraceptive Market Attractiveness Analysis 10.6.1. By Product 10.6.2. By Distribution Channel 10.6.3. By Country 11. Asia Pacific Contraceptive Market Analysis 11.1. Asia Pacific Contraceptive Market Key Findings 11.2. Asia Pacific Contraceptive Market Overview 11.3. Asia Pacific Cytometry Market Size and Forecast, by Product 11.3.1. Contraceptive Drugs 11.3.1.1. Oral Contraceptives 11.3.1.1.1. Combined Contraceptives 11.3.1.1.2. Mini-pills 11.3.1.2. Contraceptive Injectable 11.3.1.3. Topical Contraceptive Patch 11.3.2. Contraceptive Injectable 11.3.2.1. Male Contraceptive Devices 11.3.2.2. Female Contraceptive Devices 11.3.2.2.1. Female Condoms 11.3.2.2.2. Contraceptive Diaphragms 11.3.2.2.3. Contraceptive Sponges 11.3.2.2.4. Contraceptive Vaginal Rings 11.3.2.2.5. Intrauterine Devices 11.3.2.2.6. Sub-dermal Contraceptives Implants 11.3.3. Non-Surgical Permanent Contraception Devices 11.4. Asia Pacific Contraceptive Market Size and Forecast, by Distribution Channel 11.4.1. Hospital Pharmacy 11.4.1.1. Public 11.4.1.2. Private 11.4.2. Independent Pharmacy 11.4.3. Online Platform 11.4.4. Clinics 11.4.5. Others 11.5. Asia Pacific Contraceptive Market Forecast, by Country 11.5.1. China 11.5.2. India 11.5.3. Japan 11.5.4. Australia & New Zealand 11.5.5. Rest of Asia Pacific 11.6. Asia Pacific Contraceptive Market Attractiveness Analysis 11.6.1. By Product 11.6.2. By Distribution Channel 11.6.3. By Country 12. Latin America Contraceptive Market Analysis 12.1. Latin America Contraceptive Market Key Findings 12.2. Latin America Contraceptive Market Overview 12.3. Latin America Cytometry Market Size and Forecast, by Product 12.3.1. Contraceptive Drugs 12.3.1.1. Oral Contraceptives 12.3.1.1.1. Combined Contraceptives 12.3.1.1.2. Mini-pills 12.3.1.2. Contraceptive Injectable 12.3.1.3. Topical Contraceptive Patch 12.3.2. Contraceptive Injectable 12.3.2.1. Male Contraceptive Devices 12.3.2.2. Female Contraceptive Devices 12.3.2.2.1. Female Condoms 12.3.2.2.2. Contraceptive Diaphragms 12.3.2.2.3. Contraceptive Sponges 12.3.2.2.4. Contraceptive Vaginal Rings 12.3.2.2.5. Intrauterine Devices 12.3.2.2.6. Sub-dermal Contraceptives Implants 12.3.3. Non-Surgical Permanent Contraception Devices 12.4. Latin America Contraceptive Market Size and Forecast, by Distribution Channel 12.4.1. Hospital Pharmacy 12.4.1.1. Public 12.4.1.2. Private 12.4.2. Independent Pharmacy 12.4.3. Online Platform 12.4.4. Clinics 12.4.5. Others 12.5. Latin America Contraceptive Market Forecast, by Country 12.5.1. Brazil 12.5.2. Mexico 12.5.3. Rest of Latin America 12.6. Latin America Contraceptive Market Attractiveness Analysis 12.6.1. By Product 12.6.2. By Distribution Channel 12.6.3. By Country 13. Middle East & Africa Contraceptive Market Analysis 13.1. Middle East & Africa Contraceptive Market Key Findings 13.2. Middle East & Africa Contraceptive Market Overview 13.3. Middle East & Africa Cytometry Market Size and Forecast, by Product 13.3.1. Contraceptive Drugs 13.3.1.1. Oral Contraceptives 13.3.1.1.1. Combined Contraceptives 13.3.1.1.2. Mini-pills 13.3.1.2. Contraceptive Injectable 13.3.1.3. Topical Contraceptive Patch 13.3.2. Contraceptive Injectable 13.3.2.1. Male Contraceptive Devices 13.3.2.2. Female Contraceptive Devices 13.3.2.2.1. Female Condoms 13.3.2.2.2. Contraceptive Diaphragms 13.3.2.2.3. Contraceptive Sponges 13.3.2.2.4. Contraceptive Vaginal Rings 13.3.2.2.5. Intrauterine Devices 13.3.2.2.6. Sub-dermal Contraceptives Implants 13.3.3. Non-Surgical Permanent Contraception Devices 13.4. Middle East & Africa Contraceptive Market Size and Forecast, by Distribution Channel 13.4.1. Hospital Pharmacy 13.4.1.1. Public 13.4.1.2. Private 13.4.2. Independent Pharmacy 13.4.3. Online Platform 13.4.4. Clinics 13.4.5. Others 13.5. Middle East Contraceptive Market Forecast, by Country 13.5.1. South Africa 13.5.2. Saudi Arabia 13.5.3. U.A.E. 13.5.4. Rest of Middle East & Africa 13.6. Middle East Contraceptive Market Attractiveness Analysis 13.6.1. By Product 13.6.2. By Distribution Channel 13.6.3. By Country 14. Competition Landscape 14.1. Global Contraceptive Market Share Analysis, by Company (2022) 14.2. Company Profiles 14.2.1. Merck & Co., Inc. 14.2.1.1. Overview (HQ, Employee Strength, Business Segments) 14.2.1.2. Financials 14.2.1.3. Recent Developments 14.2.1.4. Strategy 14.2.2. Cipla Inc. 14.2.2.1. Overview (HQ, Employee Strength, Business Segments) 14.2.2.2. Financials 14.2.2.3. Recent Developments 14.2.2.4. Strategy 14.2.3. Allergan plc 14.2.3.1. Overview (HQ, Employee Strength, Business Segments) 14.2.3.2. Financials 14.2.3.3. Recent Developments 14.2.3.4. Strategy 14.2.4. Bayer AG 14.2.4.1. Overview (HQ, Employee Strength, Business Segments) 14.2.4.2. Financials 14.2.4.3. Recent Developments 14.2.4.4. Strategy 14.2.5. HLL Lifecare Limited 14.2.5.1. Overview (HQ, Employee Strength, Business Segments) 14.2.5.2. Financials 14.2.5.3. Recent Developments 14.2.5.4. Strategy 14.2.6. Mankind Pharma 14.2.6.1. Overview (HQ, Employee Strength, Business Segments) 14.2.6.2. Financials 14.2.6.3. Recent Developments 14.2.6.4. Strategy 14.2.7. Pfizer, Inc. 14.2.7.1. Overview (HQ, Employee Strength, Business Segments) 14.2.7.2. Financials 14.2.7.3. Recent Developments 14.2.7.4. Strategy 14.2.8. Teva Pharmaceutical Industries Ltd l 14.2.8.1. Overview (HQ, Employee Strength, Business Segments) 14.2.8.2. Financials 14.2.8.3. Recent Developments 14.2.8.4. Strategy 14.2.9. Mithra Pharmaceuticals 14.2.9.1. Overview (HQ, Employee Strength, Business Segments) 14.2.9.2. Financials 14.2.9.3. Recent Developments 14.2.9.4. Strategy 14.2.10. Janssen Pharmaceutical Company 14.2.10.1. Overview (HQ, Employee Strength, Business Segments) 14.2.10.2. Financials 14.2.10.3. Recent Developments 14.2.10.4. Strategy 14.2.11. Reckitt Benckiser Group plc 14.2.11.1. Overview (HQ, Employee Strength, Business Segments) 14.2.11.2. Financials 14.2.11.3. Recent Developments 14.2.11.4. Strategy
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Size (US$ Mn) Forecast, by Product Type, 2023–2033
Table 02: Global Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2023–2033
Table 03: Global Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2023–2033
Table 04: Global Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2023–2033
Table 05: Global Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2023–2033
Table 06: Global Market Size (US$ Mn) Forecast, by Distribution Channel, 2023–2033
Table 07: Global Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2023–2033
Table 08: Global Market Size (US$ Mn) Forecast, by Region, 2023–2033
Table 09: North America Market Size (US$ Mn) Forecast, by Country, 2023–2033
Table 10: North America Market Size (US$ Mn) Forecast, by Product Type, 2023–2033
Table 11: North America Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2023–2033
Table 12: North America Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2023–2033
Table 13: North America Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2023–2033
Table 14: North America Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2023–2033
Table 15: North America Market Size (US$ Mn) Forecast, by Distribution Channel, 2023–2033
Table 16: North America Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2023–2033
Table 17: Europe Market Size (US$ Mn) Forecast, by Country, 2023–2033
Table 18: Europe Market Size (US$ Mn) Forecast, by Product Type, 2023–2033
Table 19: Europe Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2023–2033
Table 20: Europe Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2023–2033
Table 21: Europe Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2023–2033
Table 22: Europe Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2023–2033
Table 23: Europe Market Size (US$ Mn) Forecast, by Distribution Channel, 2023–2033
Table 24: Europe Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2023–2033
Table 25: Asia Pacific Market Size (US$ Mn) Forecast, by Country, 2023–2033
Table 26: Asia Pacific Market Size (US$ Mn) Forecast, by Product Type, 2023–2033
Table 27: Asia Pacific Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2023–2033
Table 28: Asia Pacific Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2023–2033
Table 29: Asia Pacific Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2023–2033
Table 30: Asia Pacific Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2023–2033
Table 31: Asia Pacific Market Size (US$ Mn) Forecast, by Distribution Channel, 2023–2033
Table 32: Asia Pacific Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2023–2033
Table 33: Latin America Market Size (US$ Mn) Forecast, by Country, 2023–2033
Table 34: Latin America Market Size (US$ Mn) Forecast, by Product Type, 2023–2033
Table 35: Latin America Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2023–2033
Table 36: Latin America Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2023–2033
Table 37: Latin America Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2023–2033
Table 38: Latin America Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2023–2033
Table 39: Latin America Market Size (US$ Mn) Forecast, by Distribution Channel, 2023–2033
Table 40: Latin America Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2023–2033
Table 41: Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2023–2033
Table 42: Middle East & Africa Market Size (US$ Mn) Forecast, by Product Type, 2023–2033
Table 43: Middle East & Africa Market Size (US$ Mn) Forecast, by Contraceptive Drugs, 2023–2033
Table 44: Middle East & Africa Market Size (US$ Mn) Forecast, by Oral Contraceptives, 2023–2033
Table 45: Middle East & Africa Market Size (US$ Mn) Forecast, by Contraceptive Devices, 2023–2033
Table 46: Middle East & Africa Market Size (US$ Mn) Forecast, by Female Contraceptive Devices, 2023–2033
Table 47: Middle East & Africa Market Size (US$ Mn) Forecast, by Distribution Channel, 2023–2033
Table 48: Middle East & Africa Market Size (US$ Mn) Forecast, by Hospital Pharmacy, 2023–2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Contraceptives, Market Size (US$ Mn) Forecast, 2023–2033
Figure 02: Global Market Value Share, by Product (2022)
Figure 03: Global Market Value Share, by Distribution Channel (2022)
Figure 04: Global Market Value Share, by Region (2022)
Figure 05: Global Market Value Share, by Product Type, 2023 and 2033
Figure 06: Global Market Attractiveness, by Product Type, 2023–2033
Figure 07: Global Market Value Share, by Contraceptive Drugs, 2023 and 2033
Figure 08: Global Market Attractiveness, by Contraceptive Drugs, 2023–2033
Figure 09: Global Market Value Share, by Oral Contraceptives, 2023 and 2033
Figure 10: Global Market Attractiveness, by Oral Contraceptives, 2023–2033
Figure 11: Global Market Value Share, by Contraceptive Devices, 2023 and 2033
Figure 12: Global Market Attractiveness, by Contraceptive Devices, 2023–2033
Figure 13: Global Market Value Share, by Female Contraceptive Devices, 2023 and 2033
Figure 14: Global Market Attractiveness, by Female Contraceptive Devices, 2023–2033
Figure 15: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Contraceptive Drugs, 2023–2033
Figure 16: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Contraceptive Devices, 2023–2033
Figure 17: Global Market Value Share, by Distribution Channel, 2023 and 2033
Figure 18: Global Market Attractiveness, by Distribution Channel, 2023–2033
Figure 19: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospital Pharmacy, 2023–2033
Figure 20: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Independent Pharmacy, 2023–2033
Figure 21: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Online Platform, 2023–2033
Figure 22: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Clinic, 2023–2033
Figure 23: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2023–2033
Figure 24: Global Market Value Share, by Region, 2023 and 2033
Figure 25: Global Market Attractiveness, by Region, 2023–2033
Figure 26: North America Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2023–2033
Figure 27: North America Market Attractiveness, by Country 2023–2033
Figure 28: North America Contraceptive Market Value Share, by Country, 2023 and 2033
Figure 29: North America Market Value Share, by Product Type, 2023 and 2033
Figure 30: North America Market Attractiveness, by Product Type, 2023–2033
Figure 31: North America Market Value Share, by Distribution Channel, 2023 and 2033
Figure 32: North America Market Attractiveness, by Distribution Channel, 2023–2033
Figure 33: Europe Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023–2033
Figure 34: Europe Market Attractiveness, by Country, 2023–2033
Figure 35: Europe Contraceptive Market Value Share, by Country, 2023 and 2033
Figure 36: Europe Market Value Share, by Product, 2023 and 2033
Figure 37: Europe Market Attractiveness, by Product, 2023–2033
Figure 38: Europe Market Value Share, by Distribution Channel, 2023 and 2033
Figure 39: Europe Market Attractiveness, by Distribution Channel, 2023–2033
Figure 40: Asia Pacific Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2023–2033
Figure 41: Asia Pacific Market Attractiveness, by Country 2023–2033
Figure 42: Asia Pacific Market Value Share, by Country, 2023 and 2033
Figure 43: Asia Pacific Market Value Share, by Product Type, 2023 and 2033
Figure 44: Asia Pacific Market Attractiveness, by Product Type, 2023–2033
Figure 45: Asia Pacific Market Value Share, by Distribution Channel, 2023 and 2033
Figure 46: Asia Pacific Market Attractiveness, by Distribution Channel, 2023–2033
Figure 47: Latin America Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2023–2033
Figure 48: Latin America Market Attractiveness, by Country 2023–2033
Figure 49: Latin America Market Value Share, by Country, 2023 and 2033
Figure 50: Latin America Market Value Share, by Product Type, 2023 and 2033
Figure 51: Latin America Market Attractiveness, by Product Type, 2023–2033
Figure 52: Latin America Market Value Share, by Distribution Channel, 2023 and 2033
Figure 53: Latin America Market Attractiveness, by Distribution Channel, 2023–2033
Figure 54: Middle East & Africa Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2023–2033
Figure 55: Middle East & Africa Market Attractiveness, by Country 2023–2033
Figure 56: Middle East & Africa Market Value Share, by Country, 2023 and 2033
Figure 57: Middle East & Africa Market Value Share, by Product Type, 2023 and 2033
Figure 58: Middle East & Africa Market Attractiveness, by Product Type, 2023–2033
Figure 59: Middle East & Africa Market Value Share, by Distribution Channel, 2023 and 2033
Figure 60: Middle East & Africa Market Attractiveness, by Distribution Channel, 2023–2033
Figure 61: Global Drugs Market Share, by Company, 2022
Figure 62: Global Devices Market Share, by Company, 2022
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
What is the market value for contraceptives in 2023?
The global contraceptives market is valued at US$ 33 billion in 2023.
Which contraceptive product accounts for a leading market share?
Contraceptive devices hold 50% share of the global market in 2023.
What is the predicted growth rate for the contraceptives market?
Sales of contraceptives are set to increase at a CAGR of 6.5% through 2033.
Who are the key suppliers of contraceptives?
Evofem Biosciences, CooperSurgical, Inc., and Actavis, Inc. are the top producers of contraceptives.
How big will the market for contraceptives be by 2033?
Worldwide demand for contraceptives is forecasted to reach a market value of US$ 62 billion by 2033.
Contraceptives Market